Aug 13, 2025
Uveitis remains one of the leading causes of preventable vision loss worldwide, accounting for nearly 10–15% of blindness cases in developed countries. Its complex and multifactorial nature poses significant diagnostic and therapeutic challenges, demanding prompt detection and targeted intervention to preserve sigh...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market
Mar 02, 2026
-Agonist.png "Toll-like Receptors Agonist")
Newsletter/Whitepaper